# FDA Inspection 1086471 - Catalent Pharma Solutions LLC - February 01, 2019

Source: https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/576a552f-e974-4bb7-8373-a2cd1ab49144
Source feed: FDA_Inspections

> FDA Inspection 1086471 for Catalent Pharma Solutions LLC on February 01, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086471
- Company Name: Catalent Pharma Solutions LLC
- Inspection Date: 2019-02-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1229061 - 2024-05-24](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/94f7b472-03a3-4b38-89b4-0e7c1214c26e)
- [FDA Inspection 1195585 - 2022-12-15](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/7112a2e8-ff38-4600-8d7e-03bec0917ecd)
- [FDA Inspection 1131607 - 2020-09-28](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/97ae5f82-ff4f-4676-b3ee-7472c0837575)
- [FDA Inspection 1116748 - 2019-12-20](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/cf22b4d6-d3be-4a17-8b1d-02c408cffc02)
- [FDA Inspection 1081169 - 2019-03-04](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/64a671f9-d3ae-44cc-9c83-ab84dbdd6d47)

Company: https://www.keypedia.com/companies/catalent-pharma-solutions-llc/1080c7fd-2536-4ea5-9a11-18fc6317081b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c